Views & Analysis Are microtaggants the key to making medicines smarter? Pharmaceutical companies are accountable for ensuring that their medicine is safe when it comes into the hands of patients.
Digital Now what? The future of clinical trials after the pandemic Sheila Rocchio highlights four key areas life sciences must improve on as an industry to drive real change in how clinical trials are conducted.
Views & Analysis AI, big data and real world evidence – the challenges and op... Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights and innovations in medicine.
Views & Analysis The Online Safety Bill: a step towards digitally safe mental... The UK government’s Online Safety Bill has been
Sales & Marketing Key insights for a successful first-time product launch Pre-commercial & Emerging pharma companies may not think they have the resources to match the launch strategies of big pharma.
Videos Health Innovators: Teresa Arroyo-Gallego, nQ Medical In this episode of our Health Innovators series, Paul Tunnah is joined by Teresa Arroyo-Gallego, chief data scientist at artificial intelligence technology company nQ Medical.
News Aspen, Bambusa close IPOs as Corxel takes SPAC route Aspen Neuroscience and Bambusa Therapeutics get their Nasdaq IPOs over the line, while Corxel eyes a debut via a blank-cheque company merger.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.